The Margin podcast cover art

The Margin · Medical

ASC Management Companies: What They Do, What They Typically Charge and How to Compare Them

Episode 30 · November 4, 2026 · 6 min

ASC management companies promise scale, leverage, and higher margins, but that comes bundled with a fee and an equity stake you need to understand before you sign anything. We break down the real numbers behind these deals and what to calculate before your next meeting with one.

Chapters:
0:06 Cold Open
0:20 The Setup
0:52 The Scale Pitch
1:34 What They Charge, and Why the Multiples Matter
2:26 Why Owners Sign, and What They Give Up
3:11 Where Regulation Changes the Math
4:39 What To Actually Do
5:52 Close

Free guide, The 2027 ASC State of the Union: https://sigmatic.ai/guide
Book a free consultation: https://sigmatic.ai/contact

#asc #surgerycenter #ambulatorysurgery #healthcarefinance #orutilization #ascmanagement #surgerycenters #healthcarebusiness #revenuecycle

Chapters

  1. 00:06 Cold Open
  2. 00:20 The Setup
  3. 00:52 The Scale Pitch
  4. 01:34 What They Charge, and Why the Multiples Matter
  5. 02:26 Why Owners Sign, and What They Give Up
  6. 03:11 Where Regulation Changes the Math
  7. 04:39 What To Actually Do
  8. 05:52 Close

Transcript

Read the full transcript Every episode is transcribed, searchable, and quotable. Plain text

Sigmatic: Here's a sentence that should stop you mid sip of coffee. So today we're going to talk about what these companies actually do, what they charge, and the questions that keep you from signing away more than you meant to.

Sigmatic: An A S C management company takes over the day to day running of the business. Revenue cycle and billing, supply chain and implant contracting, staffing and payroll, scheduling and block management, regulatory and accreditation work. In exchange, they charge a fee, commonly reported at four to seven percent of net revenue, and they usually take an equity stake in the center on top of that. Two separate things, one fee, one ownership slice, and both need their own negotiation.

Sigmatic: The whole pitch for bringing one of these companies in is scale. A company negotiating supply contracts across dozens of centers has leverage a four room independent center simply does not have. Same story with staffing flexibility and payer rate negotiation. And that scale shows up in the numbers. Centers under three million dollars in revenue run E B I T D A margins near twelve point eight percent. Centers over nine million dollars run near thirty-seven point three percent. That's a massive gap. Size alone doesn't close it, but size buys you tools that help close it, and that's the honest version of the sales pitch, not the glossy one.

Sigmatic: So the fee is four to seven percent of net revenue, commonly. Before you sign anything, run that percentage against your center's actual net revenue, in real dollars, and compare it to what it would cost to build those same functions in house. That means pricing out a strong administrator and a materials manager who can actually do implant pricing work, not just order from habit. Now here's why management companies care so much about your margin. Single specialty centers sell for around five to eight times E B I T D A. Multi specialty centers, six to ten times. Platforms built by management companies, eleven to seventeen times. Improve your margin, and that equity stake they took is worth a lot more at the next sale. For them and for you. That alignment is real. It's just not free.

Sigmatic: The case for bringing one in usually comes down to one of three things. You don't have the bandwidth to run payer contracting and supply chain competitively. You want access to a platform's purchasing scale. Or you're prepping the center for sale and want the margin profile that supports a higher multiple before you go to market. The case against is control. If your center already runs a disciplined block schedule, costs its own cases by procedure and surgeon, and keeps supply cost per case near the benchmark of twenty-one point six percent of collections, you have less to gain from outsourcing and a much stronger hand in negotiating fee and equity if you still decide to proceed. This isn't a good guy, bad guy question. It's a does your own data justify the fee question.

Sigmatic: Two regulatory pieces matter a lot here. First, certificate of need. Thirty-five states plus D C run some form of C O N program, though several exempt A S Cs or use a lighter review. A management company with experience in your specific state's C O N process can shorten a timeline that otherwise runs twelve to twenty-four months from feasibility to first case. Second, the CY2026 Medicare rule added five hundred sixty procedures to the A S C covered list, including two hundred seventy-one codes carried over from the inpatient only list phase out, plus thirty-five ancillary services, along with a two point six percent payment update for centers that meet quality reporting requirements. Miss A S C Quality Reporting and you lose two percentage points off that update. A management company that already has reporting infrastructure built across its portfolio can be the difference between capturing that update and missing it. That's one of the more concrete, measurable arguments for signing, separate from the fee math. On top of that, Medicare has been pushing toward site neutral payment, paying the same rate regardless of where a procedure happens, and hospital outpatient rates are generally still higher than A S C rates today. As that gap narrows, hospitals want more A S C capacity of their own, which is part of why joint ventures with health systems have gotten more common. A management company with hospital relationships can be your way into one of those deals. It can also be bidding against you for the same one.

Sigmatic: Here's your homework for this quarter, and it's not complicated. Calculate your current net revenue and run the four to seven percent fee range against it, in dollars, before you take a single meeting with a management company. Cost your top twenty procedures by actual consumption, not preference card, and compare your supply cost per case and block utilization against the benchmarks we mentioned. If you're already close to those numbers, you've got a weaker case for outsourcing and a stronger negotiating position on fee and equity if you proceed anyway. Then, before you sign anything, ask for a reference center, request their actual case cost and block utilization data, not an aggregate margin claim, and confirm your state's C O N requirements up front. Also get specific about the fee itself, what happens to the equity if the center underperforms or you want to exit, which functions are done directly versus subcontracted, the term length and exit clause, and who owns your scheduling, billing and payer contract data if the relationship ends. I'll put the links in the description for our deeper pieces on opening a center, hiring a consultant, and the full A S C compliance checklist, all worth a read before you sign anything.

Sigmatic: Management companies aren't good or bad. They're a trade, your fee and a piece of equity for their scale and infrastructure. Whether that trade makes sense depends entirely on where your own numbers sit right now, not on how good the pitch sounds in the room. If you want to make your A S C more profitable, book a free consultation with us at sigmatic dot A I. The links are below in the show notes. Thanks for spending this time with us on The Margin, and we'll see you next episode.

After the episode

Want a more profitable ASC?

Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.

Make your ASC more profitable.

A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.